Date: Wednesday, June 11, 2025
Time: 1:00 pm - 2:00 pm ET
Using examples of events that have been reported to the ISMP National Medication Errors Reporting Program (ISMP MERP), data from cost-effectiveness research studies, and first-hand experience shifting an organization toward use of RTA products, the faculty will describe the key vulnerabilities when IV medications require manipulation at the bedside that have led to errors and patient harm, show attendees how they can review their own data to compare the cost and safety of manufacturer-prepared RTA products compared to traditional vial-and-syringe products, and illustrate the steps needed to successfully optimize use of RTA products in their organizations.
Intended Audience
- Medication Safety and Patient Safety Officers
- Risk Management and Quality Managers
- Medication Safety Committees
- Pharmacists
- Pharmacy Technicians
- Nurses
- Physicians
Learning Objectives
- Describe three risks associated with preparation and administration of IV medications.
- Evaluate the cost differential of manufacturer-prepared ready-to-administer (RTA) products versus traditional vial and syringe products.
- Explain the implementation steps needed to move from traditional vial and syringe products to RTA products.
Speakers
Christina Michalek, BS, RPh, FASHP, Director, Membership & PSO
John Hertig, PharmD, MS, CPPS, FASHP, FFIP, Founder, Hertig Healthcare Advising, Adjunct Assistant Professor, Purdue University
Ryan Haumschild, PharmD, MS, MBA, CPEL, Vice President of Ambulatory Pharmacy, Department of Pharmaceutical Services, Emory Healthcare and Winship Cancer Institute
CE Accreditation
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education and Institute for Safe Medication Practices. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy Continuing Education
Partners designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-25-179-L05-P/T)
Type of Activity: Knowledge
Funding Source: This activity is supported by Fresenius Kabi.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.
